CWS
VIVO

Confluence Wealth Services’s Meridian Bioscience Inc VIVO Stock Holding History

Confluence Wealth Services’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-198
Closed -$4K – 1274
2021
Q4 		$4K Buy
+198
New +$3.8K ﹤0.01% 1096

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Confluence Wealth Services's VIVO Position: Q1 2022 in Review

Confluence Wealth Services sold out of Meridian Bioscience Inc (VIVO) in Q1 2022, closing a stake of 198 shares — an estimated $4K sold.

Confluence Wealth Services first reported a position in VIVO in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.

  • Confluence Wealth Services reported no remaining Meridian Bioscience Inc position as of Q1 2022 after selling out during the quarter.
  • Confluence Wealth Services sold 198 Meridian Bioscience Inc shares in Q1 2022, an estimated $4K.
  • Confluence Wealth Services first reported a position in Meridian Bioscience Inc in Q4 2021 and held it in 1 quarter.
  • Confluence Wealth Services's Meridian Bioscience Inc position peaked at $4K in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.

Based on Confluence Wealth Services's 13F filing for Q1 2022, filed 26 Apr 2022.